MeiraGTx (NASDAQ:MGTX – Get Free Report) had its price objective raised by Royal Bank of Canada from $11.00 to $13.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has ...
In comes, DeepSeek, a Chinese AI startup that has shown it is possible to develop AI models without spending much. It ...
In a report released on March 14, Lisa Walter from RBC Capital maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report), with a ...
Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) on March 14 and set a price ...
Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...
MeiraGTx Holdings plc has recently released its 10-K report, offering insight into the company's financial condition and ...
MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...
UiPath Inc. PATH was down, falling 16% to $10.00 after the company reported a fourth-quarter revenue miss and issued ...
Hologen is paying MeiraGTx $200 million upfront and committing $230 million to fund Hologen Neuro AI and a Parkinson's disease gene therapy.
With MeiraGTx eyeing up how to take the drug through phase 3 and onto commercialization, Hologen has stepped in. The ...
Joint venture, Hologen Neuro AI, will expedite Phase 3 development of AAV-GAD for Parkinson’s Disease and industrialize ...
6d
MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback